APP下载

环磷酰胺联合泼尼松治疗特发性间质性肺炎的疗效及对患者肺功能的影响研究

2019-08-13张学勇

中国医学创新 2019年16期
关键词:肺功能

张学勇

【摘要】 目的:分析討论对特发性间质性肺炎患者使用环磷酰胺和泼尼松联合治疗的具体效果和实际价值。方法:选取本院2015年1月-2017年12月特发性间质性肺炎(idiopathic interstitial pneumonia,IIP)患者76例,根据入院先后将其均分为两组,每组各38例。对照组给予泼尼松进行治疗,观察组在服用泼尼松的基础上继续服用环磷酰胺。比较两组治疗前后呼吸困难修正评分量表(MMRC)评分、ADL生活质量评分、肺功能和总有效率。结果:治疗前,两组MMRC评分和ADL评分比较,差异均无统计学意义(P>0.05);治疗后,观察组MMRC评分低于对照组,ADL生活质量评分高于对照组(P<0.05)。治疗前,两组各项肺功能指标比较,差异均无统计学意义(P>0.05);治疗后,观察组各项肺功能指标均明显优于对照组(P<0.05)。观察组总有效率94.74%明显高于对照组71.10%,差异有统计学意义(P<0.05)。结论:对特发性间质性肺炎患者使用环磷酰胺和泼尼松联合治疗能提高患者生活质量,降低呼吸难度,并改善肺部功能,整体治疗效果优异,可在临床上进行全面推广使用。

【关键词】 环磷酰胺; 泼尼松; 特发性间质性肺炎; 肺功能

【Abstract】 Objective:To analyze and discuss the specific effect and practical value of Cyclophosphamide plus Prednisone in the pulmonary function for idiopathic interstitial pneumonia(IIP)patients.Method:76 IIP patients treated from January 2015 to December 2017 in our hospital were selected and divided into control group(n=38)and observation group(n=38)according to the admission sequence,38 cases in each group.The control grouptreatedwithPrednisone.While the observation group treated with Cyclophosphamide on the basis of Prednisone.The modified British medical research council(MMRC)scores,activity of daily living(ADL)scores,pulmonary function and total effective rate between the two groups before and after treatmentwerecompared.Result:Before treatment,the MMRC score and ADL score of the two groups were compared,the differences were not statistically significant(P>0.05).After treatment,the MMRC score in the observation group was lower than that in the control group,while the ADL score in the observation group was higher than that in the control group(P<0.05).Before treatment,the pulmonary function of the two groups were compared,the differences were not statistically significant(P>0.05).After treatment,the pulmonary function in the observation group was significantly better than that in the control group(P<0.05).The total effective rate in the observation group was 94.74% significantly higher than the control group of 71.10%,the difference was no statistically significant(P<0.05).Conclusion:The combined therapy of Cyclophosphamide and Prednisone for patients with IIP can improve the life quality,relieve the dyspnea,improve the pulmonary function.The overall treatment effect is excellent,it can be widely used in clinical practice.

【Key words】 Cyclophosphamide; Prednisone; Idiopathic interstitial pneumonia; Pulmonary function

First-authors address:963rd Hospital of the Joint Logistic Support Force of PLA,Jiamusi 154007,China

doi:10.3969/j.issn.1674-4985.2019.16.015

特发性间质性肺炎(idiopathic interstitial pneumonia,IIP)也被称为特发性肺间质纤维化,目前临床上尚未知晓该疾病具体发病原因,但在疾病发展过程中,患者会出现慢性弥漫性肺泡炎或者肺泡结构紊乱,导致肺泡结构完全遭到破坏,最终形成肺泡腔内完全型纤维化和囊泡状的蜂窝肺[1-3]。在临床治疗中,该疾病预后效果相对较差,患者极易出现其他心血管并发症,存活时间几乎难以超过5年。现阶段对特发性间质性肺炎无特效治疗方式,但环磷酰胺和泼尼松具有一定治疗效果,可延缓病情发展[4-5]。本院对特发性间质性肺炎患者使用环磷酰胺和泼尼松联合治疗,现报道如下。

1 资料与方法

1.1 一般资料 选取2015年1月-2017年12月在本院接受治疗的特发性间质性肺炎患者76例为研究对象。纳入标准:(1)均符合特发性间质性肺炎诊断标准;(2)年龄>18岁。排除标……

登录APP查看全文

猜你喜欢

肺功能
胸腹腔镜微创手术与传统开胸手术对食管癌患者术后肺功能、炎症因子水平的影响
中药穴位贴敷联合沙美特罗替卡松粉治疗慢性阻塞性肺疾病患者有效性和安全性研究
肺福康丸对慢性阻塞性肺疾病患者肺功能CAT评分的影响
普伐他汀在改善COPD患者肺功能及生活质量中的作用
家庭延续性护理对COPD患者缓解期肺功能和生活质量的影响
多索茶碱与氨茶碱治疗支气管哮喘的临床疗效观察
上海市虹桥街道居民肺功能调查
多索茶碱与噻托溴铵联合治疗对慢性阻塞性肺疾病肺功能的影响
护理干预对哮喘患者疾病认知水平及肺功能的影响
雾化吸入联合优质护理对改善哮喘患儿肺功能的体会